Austin, United States
EQO is a pioneering biotechnology startup focused on the health and biodiversity of aquatic ecosystems. Its core mission is encapsulated in its slogan: "A biotechnology lab using eRNA and eDNA dedicated to the biodiversity and health of aquatic ecosystems".
Founded in 2018 and headquartered in the United States, EQO leverages cutting-edge environmental genomics and transcriptomics. The company utilizes eDNA and eRNA technologies to comprehensively detect and understand both invasive and endangered aquatic species. This innovative solution aids in supporting biodiversity, public health, and commercial interests associated with aquatic ecosystems such as lakes and rivers.
In its journey to enhance aquatic ecosystem understanding, EQO secured a $100.00K Pre Seed Round investment on 01 October 2022, significantly backed by Mazarine Ventures. Positioned within the Biotechnology and Health Care sectors, EQO presents a compelling opportunity for investors keen on advancing environmental health technologies.
